ALP (alkaline phosphatase) is one of the most commonly flagged values on canine bloodwork, and also one of the most misunderstood. An elevated ALP can mean liver disease, Cushing's syndrome, bone growth in young dogs, a reaction to medications, or genuinely nothing at all. The number alone does not tell you much. The context around it tells you everything.
ALP is an enzyme found in liver cells, bone, intestines, and kidneys. When cells in these tissues are damaged or under stress, ALP leaks into the bloodstream. The reference range for most labs is roughly 23 to 212 U/L, though this varies by lab and by breed. The liver is the most common source of elevated ALP in adult dogs, but it is not the only one.
In dogs over 5 years old, the most frequent causes are hepatic lipidosis (fatty liver, often secondary to obesity), Cushing's disease (hyperadrenocorticism), and cholangiohepatitis (bile duct inflammation). Medications including phenobarbital, corticosteroids, and some NSAIDs can also elevate ALP significantly. In younger dogs, bone growth and remodeling produce a bone-specific ALP isoenzyme that is completely normal.
The critical question is not whether ALP is elevated, but how elevated, for how long, and what else is going on. An ALP of 250 in an otherwise healthy 3-year-old large-breed dog on no medications is very different from an ALP of 250 in a 9-year-old overweight dog with increased thirst and a thinning coat.
ALP less than 1.5 times the upper reference limit, with no other abnormalities and no clinical symptoms, is generally not cause for alarm. It warrants monitoring on the next bloodwork in 6 months but not an immediate workup. ALP between 1.5 and 3 times the upper limit, especially with a rising trend across visits, deserves a follow-up hepatic panel including GGT, bile acids, and potentially an abdominal ultrasound. ALP above 3 times the upper limit, or any elevation combined with increased thirst, weight changes, coat changes, or lethargy, should be investigated promptly.
The most common clinical miss with ALP is the slow upward trend that never triggers alarm at any individual visit. An ALP of 180 is noted as "mildly elevated." Six months later it is 210. A year later it is 260. Each time, the answer is "we'll monitor it." But the trajectory is clear: something is changing, and the next useful evidence should be sequenced instead of guessed.
This is exactly the kind of cross-visit pattern analysis Cogua's Paw Print report is built for. When records span different dates, the report tracks every value longitudinally and flags when a trend line, not just a single number, crosses into territory that deserves attention.
If your dog's ALP is elevated, the useful next questions are: is this the same or different from the last bloodwork, would GGT or bile acids clarify whether this is liver-specific, would abdominal ultrasound change the plan, and does the overall picture justify Cushing's screening. Those are the questions that move you from passive monitoring to understanding.
Get breed-specific health guides delivered
ALP elevation is exactly the kind of marker where context decides the right action. The Paw Print scores ALP against age, breed, medication history, and supporting hepatic markers. Single-marker panic is not the answer. Pattern recognition is.
Decision support, not a diagnosis. Paw Print gives the number, the drivers, and the next moves, with clinical routes when a finding truly needs care.
Read the science →Start with what you have. Self-input powers the baseline. Records sharpen the Paw Print. Access keeps it alive. $149 one-time.
Get Your Paw Print